Results 281 to 290 of about 1,964,495 (300)

Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities

Nature, 2016
Emma Kerr, Edoardo Gaude, Christian Frezza   +2 more
exaly  

Mutant

2006
openaire   +1 more source

Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management

Ca-A Cancer Journal for Clinicians
Maxime Borgeaud, Jair Bar, Stephanie Saw
exaly  

Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor

Cell, 2018
Matthew R Janes, Lian-Sheng Li, Ulf Peters   +2 more
exaly  

Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer

Nature Reviews Cancer, 2010
William Pao
exaly  

Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion

Cancer Cell, 2015
Kensuke Tateishi, Hiroaki Wakimoto, Robert E Gerszten   +2 more
exaly  

MUTANTS

1965
openaire   +1 more source

CELL CYCLE MUTANTS

Annual Review of Genetics, 1978
openaire   +2 more sources

Rescuing the function of mutant p53

Nature Reviews Cancer, 2001
exaly  

The changing treatment landscape of EGFR-mutant non-small-cell lung cancer

Nature Reviews Clinical Oncology
Xiuning Le, Caicun Zhou, Cai-Cun Zhou
exaly